申请人:Adir et Compagnie
公开号:US06071945A1
公开(公告)日:2000-06-06
A compound selected from those of formula (I): ##STR1## wherein: R.sub.1 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, R.sub.2 represents optionally substituted aryl or heteroaryl, R.sub.3 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, their isomers and addition pharmaceutically-acceptable acid or base salts thereof and medicinal products containing the same are useful in the treatment of cancer.
从公式(I)中选择的化合物:##STR1## 其中: R.sub.1代表氢,卤素,烷基,硝基,羟基,烷氧基,三卤代烷基,三卤代烷氧基或可选择取代的氨基,R.sub.2代表可选择取代的芳基或杂环基,R.sub.3代表氢,卤素,烷基,硝基,羟基,烷氧基,三卤代烷基,三卤代烷氧基或可选择取代的氨基,它们的异构体和相应的药学上可接受的酸或碱盐以及含有它们的药物制剂在癌症治疗中有用。